Evaluation of Serum Creatinine for Estimating Glomerular Filtration Rate in African Americans with Hypertensive Nephrosclerosis: Results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study

Journal of the American Society of Nephrology

Volumn 8, Issue 2, 1997, Pages 279-287

  Toto, Robert D ^a   Kirk, Katharine A ^b   Coresh, Josef ^c   Jones, Camille ^d   Appel, Lawrence ^c   Wright, Jackson ^e   Campese, Vito ^f   Olutade, Babatunde ^g   Agodoa, Lawrence ^h  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e LAC USC MEDICAL CENTER   (United States)

^f EMORY UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^h Univ Texas Southwestern Med C ^*

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; MALE; METHODOLOGY; MIDDLE AGED; NEGRO; NEPHROSCLEROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; RENOVASCULAR HYPERTENSION; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHROSCLEROSIS; PILOT PROJECTS; UNITED STATES;

EID: 0031066982     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Klag M, Whelton P, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13-18, 1996
2. MaGee JH, Unger AM, Richardson DW: Changes in renal function associated with drug or placebo therapy of human hypertension. Am J Med 36: 795-804, 1964
3. Toto R, Coresh J, Jones C, Kirk K, the AASK Pilot Study Investigators: Serum creatinine is more precise than creatinine clearance for estimating GFR in African Americans [Abstract]. J Am Soc Nephrol 6: 406, 1995
4. Shulman NB, Ford CE, Hall WD, Blaufox D, Simon D, Langford HB, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the Hypertension Detection and Follow-up study. Hypertension 13[Suppl I]: I 80-I 93, 1989
5. Mroczek WJ, Davidov M, Gavrilovich MD, Finnerty FA: The value of aggressive therapy in the hypertensive patients with azotemia. Circulation 40: 893-904, 1969
6. Breckenridge A, Dollery CT, Parry EHO: Prognosis of treated hypertension: Changes in life expectancy and causes of death between 1952 and 1967. Q J M 39: 411-429, 1970
7. Lemann J, Bidani AK, Bain RP, Lewis EJ, Rohde RD, and the collaborative study group of angiotensin converting enzyme inhibition in diabetic nephropathy: Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Am J Kid Dis 26: 236-243, 1990
8. Walser M, Drew HH, Guldan JL: Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure. Kidney Int 44: 1145-1148, 1993
9. Trollfors B, Alestig K, Jagenburg R: Prediction of glomerular filtration rate from serum creatinine, age, sex and body weight. Acta Med Scand 221: 495-498, 1987
10. Waller DB, Fleming JS, Ramsay B, Gray J: The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 67: 42-46, 1991
11. The National Institutes of Health: U.S. Renal Data Systems Annual Report, US Renal Data Systems, 1995.
12. Blythe WD, Maddux FW: Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1986-1980. Am J Kidney Dis 28: 33-37, 1991
13. Easterling RE: Racial factors in the incidence and causation of end-stage renal disease (ESRD). Trans Am Soc Artif Intern Organs 23: 28-33, 1977
14. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12: 285-290, 1988
15. Rostand SG, Kirk KA, Rutsky EA, Pate EA: Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 306: 1276-1279, 1982
16. Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease. Arch Intern Med 151: 1359-1364, 1991
17. Walker GW, Neaton JD, Cutler JA, Neuwirth R, Cohen JD: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. JAMA 268: 3085-3091, 1992
18. van Lente F, Suit P: Assessment of renal function by serum creatinine and creatinine clearance: Glomerular filtration rate estimated by four procedures. Clin Chem 35: 2326-2330, 1989
19. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 38: 167-184, 1990
20. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-35, 1976
21. Bergstrom J, Alvestrand A, Bucht H, Gutierrez A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-up and better blood pressure control. Clin Nephrol 25: 1-6, 1986
22. Whelton PK, Klag MJ: Hypertension as a risk factor for renal disease. Hypertension 13[Suppl]: I19-I 27, 1993
23. Luke RG: Can renal failure due to hypertension be prevented? Hypertension 18[Suppl]: I139-I142, 1991
24. Shemesh O, Golbetz H, Kriss JH, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28: 830-838, 1985
25. van Lente F, Suit P: Assessment of renal function by serum creatinine and creatinine clearance: Glomerular filtration rate estimated by four procedures. Clin Chem 35: 2326-2330, 1989
26. Labeeuw M, Diaz C, Cailette A, Aissa AH, Pozet N: Estimation of GFR from serum creatinine in elderly patients: Comparison of several methods [Abstract]. Clin Nephrol 33: 6, 1990
27. Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall PM, Steffes MW: Glomerular filtration rate measurements in clinical trials. J Am Soc Nephrol 4: 1159-1171, 1993
28. Rodby RA, Ali A, Ronde RD, Lewis EJ: Renal scanning 99 mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared with iothalamate clearance GFR in diabetics [Abstract]. Acta Radiol 35: 391-395, 1994
29. Peronne RD, Steinman TI, Beck GJ, Skibinski CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of I-Iothalamate, Yb-DTPA, Tc-DTPA, and Inulin. Am J Kidney Dis XVI: 224-235, 1990
30. Ruilope LM, Alcazar JM, Hernandez E, Moreno F, Martinez MA, Rodicio JL: Does an adequate control of blood pressure protect the kidney in essential hypertension. J Hypertens 8: 525-531, 1990
31. Schuster VL: Renal clearance. In: The Kidney, 2nd Ed., edited by Seldin DW, Giebisch G, New York, Raven Press, 1994, pp 365-396.